enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. How a new FDA-approved drug can — and can’t — help people ...

    www.aol.com/fda-approved-drug-t-help-121600044.html

    How a new FDA-approved drug can — and can’t — help people with Alzheimer’s November 21, 2024 at 12:28 PM If you have a loved one with Alzheimer’s disease, you may have read about a newly ...

  3. A Revolutionary New Alzheimer’s Drug Was Just Approved by the ...

    www.aol.com/revolutionary-alzheimer-drug-just...

    Lecanemab (a.k.a. leqembi) has received full approval from the U.S. Food and Drug Administration. This is the first FDA-approved treatment to help slow the progression of Alzheimer’s disease.

  4. FDA approves a second Alzheimer's drug that can ... - AOL

    www.aol.com/news/fda-approves-second-alzheimers...

    U.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing a new option for patients in the early stages of the incurable, memory-destroying ailment. The ...

  5. Brexpiprazole - Wikipedia

    en.wikipedia.org/wiki/Brexpiprazole

    Brexpiprazole, sold under the brand name Rexulti among others, is an atypical antipsychotic medication used for the treatment of major depressive disorder, schizophrenia, and agitation associated with dementia due to Alzheimer's disease. [11] [13] [14] The most common side effects include akathisia (a constant urge to move) and weight gain. [12]

  6. Vinpocetine - Wikipedia

    en.wikipedia.org/wiki/Vinpocetine

    Vinpocetine has been used in many Asian and European countries for treatment of cerebrovascular disorders such as stroke and dementia for over three decades. [ 3 ] The FDA has tentatively ruled that vinpocetine, due to its synthetic nature and proposed therapeutic uses, is ineligible to be marketed as dietary supplement under the Federal Food ...

  7. Aducanumab - Wikipedia

    en.wikipedia.org/wiki/Aducanumab

    Aducanumab, sold under the brand name Aduhelm, is a monoclonal antibody designed to treat Alzheimer's disease. [2] [3] It is a monoclonal antibody [3] [2] that targets aggregated forms (plaque) [4] [5] of amyloid beta (Aβ) found in the brains of people with Alzheimer's disease to reduce its buildup.

  8. FDA approves a second Alzheimer’s drug that can ... - AOL

    www.aol.com/fda-approves-second-alzheimer-drug...

    First, doctors need to confirm that patients with dementia have the brain plaque targeted by the new drugs. Then they need to find a drug infusion center where patients can receive therapy.

  9. William K. Summers - Wikipedia

    en.wikipedia.org/wiki/William_K._Summers

    On March 28, 1989 U.S. Patent 4,816,456 was issued to Dr. Summers. With no findings to support allegations and concerns, Frances Oldham Kelsey closed the FDA Office of Compliance investigation, in May, 1989. Nevertheless, the Office for Drug Evaluation I, placed Summers on a secret "black list" without informing him. [27]